CL-242817 is an orally available angiotensin converting enzyme ( ACE ) inhibitor. CL-242817 inhibits the conversion of angiotensin I to angiotensin II and has blood pressure lowering activity. CL-242817 can also improve Monocrotaline ( HY-N0750 ) induced lung injury. CL-242817 can be used in the study of pulmonary fibrosis and hypertension-related diseases.
Products | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Cardiovascular Disease | Products > Research Areas > Others | Products > Signaling Pathways > Angiotensin-converting Enzyme (ACE)
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.